Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Toxins|April 27, 2023
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney DiseaseCarolla El Chamieh, Islam Amine Larabi, Solène M Laville, et al.
Kidney International Reports|August 15, 2025
Association of Phenylacetylglutamine and Cognitive Impairment in CKDHélène Levassort, Julie Boucquemont, Sophie Liabeuf, et al.
The American Journal of Clinical Nutrition|September 27, 2022
The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) StudyLu Dai, Ziad A Massy, Peter Stenvinkel, et al.
Cellular Signalling|January 3, 2023
Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney diseaseEya Hamza, Mercedes Vallejo-Mudarra, Hakim Ouled-Haddou, et al.
AIDS (London, England)|April 23, 2025
Cost-effectiveness of a 4 days-a-week triple therapy in persons living with HIV: an ancillary study of the QUATUOR trialGilles Hejblum, Samih Daher, Paul Moulaire, et al.
Kidney International Reports|June 9, 2025
Uncovering the Link Between Kynurenic Acid Pathway and Kidney FailureCarolla El Chamieh, Sophie Liabeuf, Islam Amine Larabi, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2023
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistanceSidonie Lambert-Niclot, Basma Abdi, Jonathan Bellet, et al.
Neuropharmacology|July 14, 2024
Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actionsThi Mai Loan Nguyen, Jean-Philippe Guilloux, Céline Defaix, et al.
The Lancet. HIV|May 15, 2026
Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trialRoland Landman, Lambert Assoumou, Sidonie Lambert-Niclot, et al.
BMJ Mental Health|June 24, 2026
Depressive symptoms in chronic kidney disease: the hidden role of uremic toxinsHélène Levassort, Sophie Liabeuf, Julie Boucquemont, et al.
Pageof 32